Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Ultomiris 100 mg/ml PI 18 Aug 2022
Olmesartan/Amlodipine-MYL PI 18 Aug 2022
Mayzent CMI 18 Aug 2022
Olmesartan/Amlodipine-MYL CMI 17 Aug 2022
Sevikar CMI 17 Aug 2022

New products

Product name Type Date released
Vabysmo CMI 11 Aug 2022
Vabysmo PI 11 Aug 2022
Lavione PI 10 Aug 2022
Lavione CMI 10 Aug 2022
Levophed 1:1000 PI 08 Aug 2022